Plus Therapeutics, Inc. (PSTV:NASDAQ) closed at $3.87 on July 31, 2026, unchanged on the day. The stock trades 83.5% below its 52-week high of $23.43 and 33.4% above its 52-week low of $2.90. Plus Therapeutics, Inc. is part of the Health Care sector (Medical/Dental Instruments).
In 252 trading sessions since October 23, 2025, PSTV closed higher on 82 days (33%). Its best day was April 9, 2026 (+23.66%) and its worst was January 14, 2026 (-38.30%). The stock moved 10% or more in a single session 14 times. It opened at least 5% above the previous day's high 4 times.
Cytori Therapeutics Inc is a specialty therapeutics company. It focuses to provide meaningful and quality therapeutic options with a broad utility that benefit patients and healthcare providers. The company has two therapeutic development platforms: Cytori Cell Therapy (CCT) and Cytori Nanomedicine. The CCT platform is based on the scientific discovery that the human adipose or fat tissue compartment is a source of a mixed population of stem, progenitor and regenerative cells. The Cytori Nanomedicine Platform features a versatile and novel protein-stabilized liposomal nanoparticle technology for drug encapsulation that provides the foundation to bring two drugs into early/ late-stage clinical trials.
Find more stocks like PSTV with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.